Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
暂无分享，去创建一个
Dana M. Brantley-Sieders | M. V. Estrada | W. Muller | D. Sarbassov | C. Young | R. Cook | V. Sanchez | D. Hicks | M. Williams | B. Rexer | Meghan Morrison Joly | Bayley Jones